Lee M - Search Results

1

Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa.

Sheth S, Dimichele D, Lee M, Lamour J, Quaegebeur J, Hsu D, Addonizio L, Piomelli S. Sheth S, et al. Among authors: lee m. Haemophilia. 2001 Mar;7(2):227-32. doi: 10.1046/j.1365-2516.2001.00483.x. Haemophilia. 2001. PMID: 11260285

2

A Bayesian approach to the assessment of inhibitor risk in studies of factor VIII concentrates.

Lee ML, Roth DA. Lee ML, et al. Haemophilia. 2005 Jan;11(1):5-12. doi: 10.1111/j.1365-2516.2005.01055.x. Haemophilia. 2005. PMID: 15660982

3

Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituximab/prednisone.

Lozier JN, Nghiem K, Lee M, Hodsdon B, Joe G, P Weitzel R, Tisdale JF, Hsieh M. Lozier JN, et al. Among authors: lee m. Haemophilia. 2014 Mar;20(2):e185-8. doi: 10.1111/hae.12372. Haemophilia. 2014. PMID: 24533959 Free PMC article. No abstract available.

4

The use of animal pharmacokinetic data to evaluate human dosing.

Lee ML. Lee ML. Haemophilia. 2010 May;16(3):508-9. doi: 10.1111/j.1365-2516.2009.02055.x. Epub 2009 Jun 26. Haemophilia. 2010. PMID: 19563482 No abstract available.

5

A cross-over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrate.

Thomas DP, Hampton KK, Dasani H, Lee CA, Giangrande PL, Harman C, Lee ML, Preston FE. Thomas DP, et al. Among authors: lee ml, lee ca. Br J Haematol. 1994 Aug;87(4):782-8. doi: 10.1111/j.1365-2141.1994.tb06738.x. Br J Haematol. 1994. PMID: 7986719

6

The problem of therapeutic equivalence with paired qualitative data: an example from a clinical trial using haemophiliacs with an inhibitor to factor VIII.

Lee ML, Lusher JM. Lee ML, et al. Stat Med. 1991 Mar;10(3):433-41. doi: 10.1002/sim.4780100315. Stat Med. 1991. PMID: 1902967

7

Apical-out intestinal organoids as an alternative model for evaluating deoxynivalenol toxicity and Lactobacillus detoxification in bovine.

Lee MG, Lee BR, Lee P, Choi S, Kim JH, Oh MH, Yoo JG. Lee MG, et al. Sci Rep. 2024 Dec 28;14(1):31373. doi: 10.1038/s41598-024-82928-0. Sci Rep. 2024. PMID: 39733018

8

Nutrient loading as a key cause of short- and long-term anthropogenic ecological degradation of the Salton Sea.

Hung C, Diamond C, Sinclair R, Lee MC, Stenstrom M, Freilich MA, Montgomery Q, Marquez C, Lyons TW. Hung C, et al. Among authors: lee mc. Sci Rep. 2024 Dec 28;14(1):31247. doi: 10.1038/s41598-024-82633-y. Sci Rep. 2024. PMID: 39732884

9

Anti-miR21-conjugated DNA nanohydrogel for enhanced cancer therapy.

Lee M, Hwang J, Song Y, Kim S, Park N. Lee M, et al. Biomater Adv. 2024 Dec 24;169:214160. doi: 10.1016/j.bioadv.2024.214160. Online ahead of print. Biomater Adv. 2024. PMID: 39731836

10

Rebleeding After Secondary Post-Tonsillectomy Bleeding: Risk Factors Identified From a Single-Centre Retrospective Study of 448 Cases.

Lee M, Wood A, Ahmadi O, van der Werf B, Selvarajah K. Lee M, et al. Clin Otolaryngol. 2024 Dec 28. doi: 10.1111/coa.14275. Online ahead of print. Clin Otolaryngol. 2024. PMID: 39731540 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,735 results

Search Page

Filters